eBay Inc vs Merck & Co., Inc. — how do they compare? eBay Inc trades at $113.3 (market cap $49.83B), while Merck & Co., Inc. trades at $146.21 (market cap $351.28B). The key difference: Merck & Co., Inc. is far larger — about 7× eBay Inc's market cap, and Merck & Co., Inc. pays the higher dividend (2.39%). Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Merck & Co., Inc. for 98 Days on average.
| EBAY | MRK | |
|---|---|---|
Market Cap | $49.83B | $351.28B |
Volume | 2,986,953 | 7,969,665 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $156.43 |
52-Week Low | $79.41 | $82.49 |
Typical Hold Time | 134 Days | 98 Days |
Enterprise Value | $53.65B | $398.04B |
Dividend Yield | 1.11% | 2.39% |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $112.41, up 4.47% today, showing strong momentum with three consecutive quarterly earnings beats. The stock exhibits bullish technical signals with moving averages supporting upward trends, while fundamentals reveal robust profitability with 72.05% gross margins and 47.38% ROE. Recent news highlights strategic focus on collectibles and live commerce growth, though competition intensifies as Amazon introduces multi-platform seller tools.
Outlook remains positive with analyst consensus at $117.68 target (4.7% upside), though risks include potential acquisition uncertainty from GameStop's stake and slowing advertising growth. The company's strong cash flow generation and consistent earnings performance support continued investor confidence, but monitoring competitive pressures and execution of growth initiatives is crucial for sustained outperformance.
Merck (MRK) trades at $144.96, up 1.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 72.97% gross margin and 28.07% net income margin for 2025, though its P/E ratio of 113.9 indicates high valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives amid competitive pressures.
The outlook is mixed: analyst consensus is bullish with a $158.78 price target, but technical indicators and a high P/E suggest near-term caution. Key risks include integration challenges from acquisitions and macroeconomic headwinds affecting pharmaceutical R&D investment. Revenue growth and pipeline execution remain critical for sustained upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →